Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs (Q36284079)

13 August 2017

title

Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs (English)

1 reference

13 August 2017

0 references

Grant H Skrepnek

1 reference

13 August 2017

Jacob Abarca

1 reference

13 August 2017

Daniel C Malone

1 reference

13 August 2017

Edward P Armstrong

1 reference

13 August 2017

Farshad M Shirazi

1 reference

13 August 2017

Raymond L Woosley

1 reference

13 August 2017

language of work or name

English

0 references

publication date

11 October 2005

1 reference

Annals of Pharmacotherapy

13 August 2017

published in

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

page(s)

1785-1791

1 reference

The epidemiology of heart failure: the Framingham Study

13 August 2017

cites work

1 reference

Can physicians always explain the results of clinical trials? A case study of amlodipine in heart failure

21 January 2018

1 reference

New therapeutic options in congestive heart failure: Part II.

21 January 2018

1 reference

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

21 January 2018

1 reference

Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge

21 January 2018

1 reference

National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction

21 January 2018

1 reference

Race, quality of care, and outcomes of elderly patients hospitalized with heart failure

21 January 2018

1 reference

Angiotensin-converting enzyme inhibitor therapy in patients with heart failure enrolled in a managed care organization: effect on costs and probability of hospitalization

21 January 2018

1 reference

Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopri

21 January 2018

1 reference

Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective

21 January 2018

1 reference

Congestive heart failure in the United States: is there more than meets the I(CD code)? The Corpus Christi Heart Project.

21 January 2018

1 reference

On estimating efficacy from clinical trials

21 January 2018

1 reference

The use of claims databases for outcomes research: rationale, challenges, and strategies

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1G124

1 reference

13 August 2017

1 reference